KRAS and hepatocellular carcinoma: A very recent study [16] of HIV-negative patients with severe liver disease (cirrhosis and/or hepatocellular carcinoma) showed 22% RAS compartmentalization using population (Sanger) sequencing of the NS3, NS5A, and NS5B domains across GT1a, GT1b, GT3a, and GT4d.